Patents by Inventor Laura E. Hanold

Laura E. Hanold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth
    Patent number: 11510964
    Abstract: The present technology provides methods end medicaments useful for treating prostate cancer and breast cancer. Such methods include administering at least one of cyclo[Phe-D-Pro-Phe-Trp] and cyclo[Phe-D-Pro-Phe-D-Trp] to a subject suffering from prostate cancer or breast cancer.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: November 29, 2022
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Jane Aldrich, Archana Mukhopadhyay, Laura E. Hanold
  • Macrocyclic peptides and derivatives thereof with opioid activity
    Patent number: 11325944
    Abstract: The invention relates to macrocyclic peptides and pharmaceutical compositions thereof. The invention further relates to pharmaceutical compositions for modulating opioid receptor activity.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: May 10, 2022
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: Jane V. Aldrich, Laura E. Hanold
  • MACROCYCLIC PEPTIDES TO DECREASE C-MYC PROTEIN LEVELS AND REDUCE CANCER CELL GROWTH
    Publication number: 20210308210
    Abstract: The present technology provides methods end medicaments useful for treating prostate cancer and breast cancer. Such methods include administering at least one of cyclo[Phe-D-Pro-Phe-Trp] and cyclo[Phe-D-Pro-Phe-D-Trp] to a subject suffering from prostate cancer or breast cancer.
    Type: Application
    Filed: October 16, 2020
    Publication date: October 7, 2021
    Inventors: Jane Aldrich, Archana Mukhopadhyay, Laura E. Hanold
  • MACROCYCLIC PEPTIDES AND DERIVATIVES THEREOF WITH OPIOID ACTIVITY
    Publication number: 20200109168
    Abstract: The invention relates to macrocyclic peptides and pharmaceutical compositions thereof. The invention further relates to pharmaceutical compositions for modulating opioid receptor activity.
    Type: Application
    Filed: June 15, 2018
    Publication date: April 9, 2020
    Inventors: Jane V. Aldrich, Laura E. Hanold
  • MACROCYCLIC PEPTIDES TO DECREASE C-MYC PROTEIN LEVELS AND REDUCE CANCER CELL GROWTH
    Publication number: 20190388499
    Abstract: The present technology provides methods and medicaments useful for treating prostate cancer and breast cancer. Such methods include administering at least one of cyclo[Phe-D-Pro-Phe-Trp] and cyclo[Phe-D-Pro-Phe-D-Trp] to a subject suffering from prostate cancer or breast cancer.
    Type: Application
    Filed: January 20, 2018
    Publication date: December 26, 2019
    Inventors: Jane Aldrich, Archana Mukhopadhyay, Laura E. Hanold